Diabetologie und Stoffwechsel 2019; 14(S 01): S9-S10
DOI: 10.1055/s-0039-1688131
ePoster
Digitalisierung und neue Technologien
Georg Thieme Verlag KG Stuttgart · New York

Guideline adherence and improved treatment success rates for type-2-diabetes patients with a digital platform (PDMone)

S Brenner
1   UMIT – Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik GmbH, Institut für Management und Ökonomie im Gesundheitswesen, Hall in Tirol, Austria
,
B Kulzer
2   Forschungsinstitut der Diabetes-Akademie Bad Mergentheim (FIDAM), Forschungsinstitut der Diabetes-Akademie Bad Mergentheim (FIDAM), Bad Mergentheim, Germany
,
R Daikeler
3   Internistische Gemeinschaftspraxis, Diabetologische Schwerpunktpraxis, Sinsheim, Germany
,
A Reichel
4   Universitätsklinikum 'Carl Gustav Carus' der Technischen Universität Dresden, Medizinische Klinik und Poliklinik III, Dresden, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
07 May 2019 (online)

Also available at
 
 

    Background:

    Medical guidelines provide consented process guidance to increase patients' probability for favorable outcomes. Our analysis evaluates adherence to current treatment guidelines for type-2-diabetes and the association with treatment success.

    Methods:

    In this observational study, 108 type-2-diabetes patients (64 years, 11 years of diabetes duration, 9.1% HbA1c at study start) receiving initial or adjusted insulin therapy were included in the analysis. Diabetologists used a digital platform (PDMone, Roche Diabetes Care) with integrated patient information as basis for personalized diabetes care. Full glycemic guideline-adherence was attested when all four steps were completed: Definition of individual HbA1c target, HbA1c testing at study start, therapy adjustment if HbA1c is above the individual target, evaluation of treatment success. Treatment success was assumed if patients achieved HbA1c values ≤ their individual treatment target (6.5–8.0%).

    Results:

    84% of patients were treated fully adherent to guidelines. 53% of these patients achieved treatment success. Treatment success was higher for patients with HbA1C ≤8% at study start versus patients with baseline HbA1c > 8%Treatment success was higher for new patients versus patients with longer duration of Diabetologist treatment.

    Conclusion:

    The longitudinal approach allows measuring glycemic guideline-adherence over time. Patients treated fully guideline-adherent achieve good glycemic outcomes. Digital platforms like PDMone can facilitate adherence by integrating information, by providing feedback about treatment, and by visualizing how patients are progressing against targets.


    #